Roles of caveolin-1 on anoikis resistance in non small cell lung cancer

Preedakorn Chunhacha1, Pithi Chanvorachote

  • 1Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, and Cell-based Drug and Health Products Development Research Unit, Chulalongkorn, University Bangkok 10330, Thailand.

Insights

Caveolin-1 (Cav-1) protein influences anoikis, a form of apoptosis, in Non-Small Cell Lung Cancer (NSCLC). Understanding Cav-1

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Lung cancer, particularly Non-Small Cell Lung Cancer (NSCLC), presents a significant global health challenge with high mortality rates.
  • Metastasis is frequently observed in NSCLC patients, highlighting the need for effective therapeutic strategies.
  • Caveolin-1 (Cav-1) is implicated in regulating cancer cell behaviors, including apoptosis resistance and metastasis.

Purpose of the Study:

  • This review focuses on the role and mechanism of caveolin-1 (Cav-1) in anoikis within Non-Small Cell Lung Cancer (NSCLC).
  • To elucidate the molecular basis of cancer progression and metastasis for developing novel lung cancer therapies.

Main Methods:

  • Literature review synthesizing existing research on caveolin-1 (Cav-1) and anoikis in NSCLC.
  • Analysis of cellular and molecular mechanisms underlying Cav-1's function in lung cancer.

Main Results:

  • Caveolin-1 (Cav-1) plays a crucial role in regulating anoikis in NSCLC cells.
  • Cav-1 is involved in key cancer cell behaviors such as apoptosis resistance and metastasis.

Conclusions:

  • The findings suggest that caveolin-1 (Cav-1) is a significant factor in NSCLC progression and metastasis.
  • Further in vivo investigations are warranted, but this data may inform the development of new lung cancer treatments.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...